Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10218521 | Journal of Infection | 2018 | 16 Pages |
Abstract
TB incidence was very high among those receiving renal replacement therapy or CKD 4 or 5. Most cases occurred in those of an Asian/Asian British or black/black British background. Testing and treating such patients for latent TB is justified and should include those who have been receiving renal replacement therapy for some years.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
E Moran, J Baharani, M Dedicoat, E Robinson, G Smith, P Bhomra, OS Thien, R Ryan,